Cp-690550a is a novel JAK3 inhibitor, which is used to treat rheumatoid arthritis, graft rejection, psoriasis, and other immune-mediated diseases.

1243290-37-0

C15H21N5O2

303.36

UNII-Q7ZOK859UK;Tofacitinib metabolite M2;CP-690,550A;CP-690550A

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years